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Infection of biomedical devices is characterized by biofilm formation and colonization of surrounding tissue
by the causative pathogens. To investigate whether bacteria detected microscopically in tissue surrounding
infected devices were viable, we used bromodeoxyuridine (BrdU), a nucleotide analogue that is incorporated
into bacterial DNA and can be detected with antibodies. Infected human tissue was obtained postmortem from
patients with intravascular devices, and mouse biopsy specimens were obtained from mice with experimental
biomaterial infection. In vitro experiments showed that Staphylococcus epidermidis incorporated BrdU, as
judged from staining of the bacteria with anti-BrdU antibodies. After incubation of bacteria with BrdU and
subsequent staining of microscopic sections with anti-BrdU antibodies, bacteria could be clearly visualized in
the tissue surrounding intravascular devices of deceased patients. With this staining technique, relapse of
infection could be visualized in mice challenged with a low dose of S. epidermidis and treated with dexameth-
asone between 14 and 21 days after challenge to suppress immunity. This confirms and extends our previous
findings that pericatheter tissue is a reservoir for bacteria in biomaterial-associated infection. The pathogen-
esis of the infection and temporo-spatial distribution of viable, dividing bacteria can now be studied at the
microscopic level by immunolabeling with BrdU and BrdU antibodies.
Biomaterial-associated infection (BAI) is a common and
serious problem in modern medicine. Infection necessitates
extensive antimicrobial treatment and may eventually lead to
removal or replacement of the device. This causes morbidity
and mortality and increases hospital costs considerably (11,
25). Bacteria causing these infections can be present on the
implanted material and form a biofilm (17, 23, 43), but they are
also found in the surrounding tissue (3, 7–9). Previously, we
have shown that in a mouse model of BAI, bacteria are present
in higher numbers in the tissue surrounding the implanted
material than on the biomaterial itself (3–5, 7, 8). In the tissue
the bacteria are associated with host inflammatory cells and
are found in large numbers within macrophages (3), which
suggests that these macrophages allow intracellular survival
and possibly replication of the bacteria. In mice, tissue-residing
Staphylococcus epidermidis bacteria persist despite rifampin/
vancomycin treatment (7), whereas the antibiotics do clear the
bacteria from the implanted biomaterial itself. We also de-
tected viable bacteria in samples of tissue surrounding cathe-
ters retrieved from deceased patients (9). The tissue surround-
ing foreign bodies, therefore, must be considered a niche for
bacteria that cause BAI.
The aim of our study was to investigate the spatio-temporal
characteristics of the development of the infection at the mi-
croscopic level by labeling viable bacteria in situ. Available
methods to detect and/or localize bacteria include plate and
liquid broth culture (13, 36) and various molecular diagnostic
techniques (PCR and reverse transcription-PCR [RT-PCR])
(1, 19, 34), whereas to visualize bacteria, methods such as
Gram staining, green fluorescent protein (GFP) expression
(15, 28), use of bioluminescent markers (12, 20, 42), in situ
hybridization with probes for RNA or DNA (21, 24), live/dead
fluorescent staining (16), bioluminescence imaging using in
vivo imaging systems (IVIS) (14), and immunohistochemistry
analysis (3) have been used. None of these methods, however,
allows a timed start of labeling of viable cells combined with
the possibility of microscopic detection of viable cells in situ. A
suitable method to achieve this may be labeling with bromode-
oxyuridine (BrdU). BrdU is a synthetic thymidine analogue
which is incorporated into newly synthesized DNA during
DNA replication and repair. BrdU has been used extensively
to study eukaryotic cell proliferation and other cellular func-
tions (12, 30, 31, 37, 40) and also for detection of replicating
bacteria in marine (27, 38) and soil samples (2, 6, 44). It is
readily incorporated by Escherichia coli in broth culture (18,
35). In the present study we applied BrdU labeling to investi-
gate the presence of viable bacteria in pericatheter tissue of
deceased patients and the viability of S. epidermidis on im-
plants and in surrounding tissue in a mouse BAI model. We
used dexamethasone for immune suppression to assess
whether infection in the mice could be resuscitated at 2 weeks
after a low-dose challenge with S. epidermidis.
MATERIALS AND METHODS
S. epidermidis strains and inoculum preparation. S. epidermidis strain RP62a
(ATCC 35984) was used in the mouse experimental biomaterial-associated in-
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Microbiology, Academic Medical Center, Meibergdreef 15, L1-116,
1105 AZ Amsterdam, The Netherlands. Phone: 31 20 5664863. Fax: 31
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fection model. Strain RP62a harbors the biofilm-associated icaA, atlE, aap, and
sarA genes and produces polysaccharide intercellular adhesin (PIA) and -toxin
(8). MICs according to a standard Etest of strain RP62a were the following
(g/ml): rifampin, 0.016; teicoplanin, 3; gentamicin, 8; and vancomycin, 4.
Bacteria retrieved after challenge of mice were always checked for susceptibility
to these antibiotics. S. epidermidis inocula were prepared by inoculating tryptic
soy broth (TSB) with 25 l of thawed suspension from frozen stocks and incu-
bation for 4 to 5 h at 37°C. After centrifugation and washing of the bacterial
pellet with saline, suspensions containing approximately 4  108 CFU per ml of
saline were prepared based on the optical density at 620 nm (OD620) (4).
Suspensions of E. coli ML35 (22), used as positive control strain for BrdU
incubation in in vitro experiments, were prepared in the same way (18, 35).
To assess BrdU incorporation in vitro, 150 l of the bacterial suspension was
added to 3 ml of TSB containing 10 M BrdU and 33 nM thymidine and
incubated for 2 h at 37°C. Thymidine was added to suppress thymidilate synthase
(18). Ten microliters of this suspension was added to an epoxy-coated glass slide
and treated for light-microscopic detection of BrdU as described below. Con-
centrations of up to 100 M BrdU did not influence the growth of S. epidermidis
in TSB.
Catheters and surrounding tissue from deceased patients. Tissue samples of
deceased patients were obtained in a study described previously (9). The need
for review by the Institutional Review Board of studies involving deceased
patients was waived by the Dutch Central Committee involving Human Sub-
jects (CCMO), provided that informed consent for autopsy and removal and
preserving of tissues for scientific research was given by the next of kin, in
accordance with Dutch law. When corpses are refrigerated shortly after
death, their microbiological status is expected not to change significantly (10),
and viable bacteria present in the tissue may replicate when the tissue is
placed at 37°C.
Catheters with surrounding tissue were explanted from the corpses as de-
scribed previously (9). In brief, with a carefully controlled procedure a biopsy
specimen was excised (approximately 2 to 3 cm in diameter and 4 to 8 cm in
length) which contained a catheter segment with its subcutaneous and deeper
surrounding tissue. Sample processing was performed in a laminar flow cabinet,
where the biopsy specimen was sliced and the catheter segments were removed
for separate analysis (9). The tissue was homogenized briefly to allow BrdU
penetration while preserving most of the tissue cell structures. To 100 l of this
homogenate 50 l of TSB was added with BrdU and thymidine at final concen-
trations of 10 M and 33 nM, respectively, and the mixture was incubated with
shaking overnight at 37°C. The remainder of the homogenate was processed
further for quantitative culture (9). After overnight incubation the samples from
two patients with positive cultures were used to prepare slides for BrdU detec-
tion. Ten microliters of sample was transferred to epoxy-coated slides, fixed with
2% paraformaldehyde, and stained for immunodetection of BrdU by light mi-
croscopy, as described below.
BrdU incorporation in S. epidermidis bacteria in a mouse BAI model. Mouse
BAI studies were approved by the Animal Ethical Committee of the University
of Amsterdam and were performed as described earlier (3–5, 7, 8). In a pilot
experiment, four mice were anesthetized with FFM mix (1 ml of fentanylcitrate,
1 ml of midazalam, and 2 ml of distilled water), and a 1-cm-long segment of
polyvinylpyrrolidone-grafted silicon elastomer (SEpvp) catheter (diameter, 2.5
mm; wall thickness, 0.6 mm [Medtronic PS Medical, Goleta, CA]) was implanted
subcutaneously on each side of the back. The incisions were closed with a single
stitch (Vicryl 6/0), and the bacterial inoculum (107 CFU in 25 l of saline) was
injected subcutaneously along the implanted segments. On day 2, along each
implanted segment two mice were injected subcutaneously with 50 l of 10 M
BrdU–33 nM thymidine, and two mice were injected with 50 l of 0.9% NaCl.
One BrdU-injected mouse and one control mouse were sacrificed after 4 h,
whereas the other two mice were sacrificed after 24 h, as described below.
Subsequently, three groups of nine mice anesthetized with FFM mix received
SEpvp catheter segments, and a bacterial inoculum of 106 S. epidermidis CFU in
25 l of saline was injected alongside each implanted segment. Previous studies
showed that after infection with this size of inoculum, only small numbers of
bacteria are cultured from the mice after 14 days (4). When such bacteria are
dividing in situ, they should incorporate BrdU and should be detectable after
immunostaining for BrdU.
We hypothesized that treatment of mice with the immunosuppressive agent
dexamethasone starting 14 days after challenge might result in reactivation or
relapse of the infection and that multiplying bacteria would incorporate BrdU.
Therefore, one group of nine mice was sacrificed after 14 days to determine the
number of CFU present at this time point of the experiment. The other two
groups of mice received subcutaneous injections of 50 l of BrdU-thymidine at
the implantation sites every 2 days between day 14 and day 21 under mild
anesthesia (isoflurane/oxygen). One of these groups received daily intraperito-
neal injections of dexamethasone (3 mg/kg of body weight), and the other
(control) group received saline injections.
At day 21 the mice were sacrificed under full anesthesia. Prior to cardiac
puncture a standardized biopsy specimen of 12 mm in diameter comprising the
implant with surrounding tissue was taken from each implantation site. The
right-side biopsy specimen was used for quantitative culture; the left-side biopsy
specimen was cut into halves; one half was used for quantitative culture and the
other half used for histology. The implants were rinsed and then sonicated for
30 s in 500 l of saline. The sonicate was cultured quantitatively by plating six
10-l aliquots of undiluted sonicate (detection limit of 5 CFU) and of 10-fold
serial dilutions of the sonicate. The implant itself was placed in 80 ml of liquid
Brewer Tween broth ([BT] 3% [wt/vol] thioglycolate broth containing 0.03%
[wt/vol] polyanetholesulfonic acid and 0.5% Tween 80, adjusted to pH 7.6 with 1
M NaOH). Cultures were incubated for up to 14 days at 37°C. When plate
cultures were negative while the corresponding BT culture was positive, we
considered the implants to have been colonized with 5 CFU of bacteria. The
12-mm-diameter tissue samples were homogenized and cultured quantitatively.
In addition, a 1/10 volume of the homogenate was cultured in 80 ml of BT broth
for up to 14 days at 37°C. If this BT broth culture was positive and the plate
cultures were negative, the total homogenate was considered to have contained
10 CFU of bacteria since 1/10 of the homogenate had been cultured. Positive BT
broth cultures of any of the implants or tissue samples were streaked on blood
agar plates that were incubated overnight at 37°C. The culture results were used
to calculate the total numbers of CFU present on the entire implant and in the
entire tissue biopsy specimen. Twenty-five microliters of blood was cultured in 80
ml of BT broth for up to 14 days at 37°C. Blood cultures were negative for all
samples.
For histological confirmation of the microbiological findings, mouse tissue
biopsy specimens were fixed in formaldehyde and embedded in plastic (meth-
ylmethacrylate/buthylmethacrylate [MMA/BMA]; Merck Schuchart, Hohen-
brunn, Germany). Sections of 5 m were cut and transferred to microscopic
slides. The plastic was removed, and sections were fixed in paraformaldehyde
and rinsed with Tris-HCl buffer (50 mM, pH 7.4) for 15 min.
BrdU staining for light microscopy. A BrdU detection kit (BD Biosciences)
was used according to the manufacturer’s protocol. Briefly, slides were incubated
in fixation and diluent buffer (BrdU detection kit; BD Biosciences) for mem-
brane permeabilization, followed by an incubation in 10 l of 3% H2O2 and
RetrievAgen A working solution (BrdU detection kit; BD Biosciences) at 89°C.
Slides were cooled to room temperature, rinsed, and incubated with anti-BrdU–
biotin for 1 h, and subsequently with streptavidin-horseradish peroxidase (HRP)
for 30 min. Bound antibodies were visualized with 3,3-diaminobenzidine (DAB)
substrate, and slides were inspected by light microscopy for characteristic dark-
brown staining. This procedure was also performed with E. coli strain ML35 and
with UV-killed S. epidermidis strain RP62a as positive (18, 35) and negative
controls, respectively. Sections were either counterstained with hematoxylin-
eosin (HE) or subjected to Gram staining.
Staining for fluorescence microscopy. BrdU detection was performed as de-
scribed above, with anti-BrdU–Alexa Fluor 488. S. epidermidis bacteria cultured
in the absence of BrdU were routinely included as controls in experiments with
the anti-BrdU–Alexa Fluor 488 and were always negative (data not shown).
Sections were also stained with anti-lipoteichoic acid (LTA; QED, Bioscience
Ltd. San Diego, CA) (7) to identify S. epidermidis and to show that anti-BrdU-
positive particles would, indeed, be replicated in S. epidermidis. Anti-LTA was
labeled with a Zenon Alexa Fluor 488 mouse IgG1 labeling kit (Invitrogen-
Molecular Probes, Breda, The Netherlands) or covalently linked with Alexa
Fluor 568 (Invitrogen-Molecular Probes), according to the manufacturer’s pro-
tocols. The labeled antibodies were applied to the slides at a concentration of 2.5
g/ml, and slides were incubated for 60 min at room temperature. Anti-LTA
specifically binds to Gram-positive bacteria containing LTA in their cell walls.
Gram-negative bacteria or uninfected mammalian tissue did not show any signal
(data not shown).
For combined staining, slides were incubated for 1 h with anti-LTA–Alexa
Fluor 568, rinsed, and incubated for 10 min with RetrieveAgen solution in a 89°C
water bath. Slides were allowed to cool to room temperature (in approximately
20 min), rinsed, and then incubated for 1 h with anti-BrdU–Alexa Fluor 488 in
a humid chamber. All slides were mounted with 15 l of Vectashield hard-set
mounting medium containing 4,6-diamidino-2-phenylindole ([DAPI] H1500;
Brunswig Chemie) to visualize DNA and inspected using a Leica SP2 confocal
microscope (Leica, Rijswijk, The Netherlands).
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RESULTS
BrdU incorporation and detection in S. epidermidis RP62a in
vitro. To determine whether BrdU incorporation takes place in
S. epidermidis RP62a, bacteria were incubated with BrdU and
thymidine for 2 h, and incorporation of BrdU was investigated
by immunomicroscopy with anti-BrdU–HRP. A positive signal
(brown staining of the bacteria) was observed only when bac-
teria had been grown in the presence of BrdU and when
anti-BrdU was used in the staining procedure (Table 1). No
staining was observed when heat-killed S. epidermidis cells
were used. E. coli, the positive control, also was stained as a
result of BrdU incorporation.
FIG. 1. Confocal image of S. epidermidis RP62A grown with BrdU, stained with anti-BrdU–Alexa Fluor 488 (green signal; A) and anti-LTA–
Zenon Alexa Fluor 594 (red signal; B). DNA is stained blue by the DAPI included in the Vectashield mounting medium (C). An overlay of all
the fluorescence channels (D) clearly shows full overlap of all signals.
TABLE 1. Labeling of S. epidermidis with BrdUa
Bacterium
Treatment Result
BrdU Anti-BrdU Anti-BrdUstaining
Gram
staining
S. epidermidis    
S. epidermidis    
S. epidermidis    
S. epidermidis    
Heat-killed S. epidermidis    
E. coli    
a Bacteria were incubated with or without BrdU for 4 h, and slides were
treated with or without anti-BrdU–biotin and incubated with streptavidin-HRP
and DAB substrate. Brown-stained bacteria were positive for incorporation of
BrdU. As a control, slides were Gram stained to verify the presence of bacteria
on the slides.
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Subsequently, S. epidermidis RP62a cells grown in the pres-
ence of BrdU were stained with both anti-LTA–Zenon Alexa
Fluor 594 and anti-BrdU–Alexa Fluor 488. Slides were in-
spected by confocal microscopy. The confocal image showed
fluorescently labeled bacteria due to anti-BrdU (Fig. 1A,
green) and anti-LTA (Fig. 1B, red) binding, with DNA stained
blue due to the presence of DAPI in the mounting medium
(Fig. 1C). In the overlay (Fig. 1D) all colors merged, showing
that the bacteria had incorporated BrdU. Bacteria incubated
without BrdU showed only red and blue fluorescence (data not
shown). As a result of the heating step required to denature
the DNA in order to make it accessible for anti-BrdU, the
anti-LTA signal was rather weak and had to be amplified. As
this most likely was due to dissociation of the anti-LTA–Zenon
Alexa Fluor 594 complex, anti-LTA covalently coupled to Alexa
Fluor 568 was used in further experiments.
Bacterial presence and growth in homogenates of tissue
surrounding catheters from deceased patients. Slides of peri-
catheter tissue from biopsy specimens obtained from deceased
patients incubated overnight with BrdU-thymidine showed
positively stained cocci in immunomicroscopy with anti-BrdU
(Fig. 2, arrowheads; the result is representative for both pa-
tients), proving that BrdU had been incorporated and that
bacteria had replicated in situ. The tissue was not stained,
showing that no nonspecific binding had taken place and that
viable bacteria could clearly be discriminated in these ex vivo
tissue samples.
BrdU incorporation by S. epidermidis in experimental BAI.
Sections were prepared of biopsy specimens of mice that had
received either BrdU or saline at 3 days after challenge and
were sacrificed 1 day later. Alternating slides were stained by
Gram and fluorescent staining. Gram-positive bacteria were
seen both at the biomaterial-tissue interface and within the
tissue surrounding the implants, often in association with cells
(Fig. 3A to C). In confocal microscopy, slides treated with
anti-BrdU–Alexa Fluor 488 and anti-LTA–Alexa Fluor 568
showed particles the size of bacteria which were stained green
and red, respectively (Fig. 3D and E). In the overlay, these
particles were yellow (Fig. 3F), thus confirming that they were
S. epidermidis cells which had replicated within the host tissue
in vivo.
Incorporation of BrdU by S. epidermidis in vivo after immune
suppression of mice with dexamethasone. Next, we assessed
whether S. epidermidis bacteria were still viable and able to
replicate between 14 to 21 days after inoculation in the mouse
BAI model and whether replication would be enhanced if the
mice were immunosuppressed by dexamethasone treatment.
Twenty-seven mice carrying biomaterial implants were chal-
lenged with S. epidermidis. After 14 days nine mice were sac-
rificed to determine the level of colonization prior to the start
of dexamethasone administration. Nine of the 18 tissue biopsy
specimens yielded growth, whereas only 1 of the 18 implants
was culture positive (Fig. 4). Between 14 and 21 days the
remaining 18 mice received BrdU injections combined with
either dexamethasone or saline injections. In the group of nine
mice that had received BrdU as well as dexamethasone injec-
tions, 10 of 18 tissue biopsy specimens and 2 of 18 implants
yielded bacterial growth after 21 days. In the control group,
FIG. 2. Microscopic analysis of homogenate of the pericatheter tissue of a deceased patient. Homogenates were incubated overnight with
BrdU, and BrdU incorporation was investigated by immunomicroscopy. Brown staining indicates the presence of bacteria that have incorporated
BrdU (arrowheads). Bar, 10 m.
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FIG. 3. Microscopic analysis of biopsy specimens of mice with experimental biomaterial-associated infection injected with BrdU. (A to C) Gram
staining of representative sections of biopsy specimens from mice sacrificed at 4 and 24 h after bacterial challenge. (D and E) Confocal microscopy
image of a mouse biopsy specimen slide stained with anti-BrdU (D) and anti-LTA (E). (F) Overlay of the images shown in panels D and E. Bar,
10 m.
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which had received BrdU and saline, 16 of 18 tissue biopsy
specimens and 1 of 18 implants yielded growth.
In all groups significantly more tissue biopsy specimens than
corresponding implants were culture positive. In mice treated
with BrdU and dexamethasone as well as in mice that had
received BrdU and saline, the numbers of CFU in the tissue at
21 days were significantly higher than at day 14 (P  0.007)
(Fig. 4) when dexamethasone and BrdU administration had
been started. In mice treated with BrdU and saline, the num-
ber of culture-positive tissue biopsy specimens had increased
between 14 and 21 days (P  0.03).
In microscope slides of biopsy specimens of the mice sacri-
ficed after 14 days, Gram-positive bacteria were observed in
the tissue (data not shown). Positive staining for BrdU was
observed in samples of both groups that had received BrdU
injections (Fig. 5). This showed that BrdU allows detection of
replicating S. epidermidis in situ in the mouse model. More-
over, the results show that S. epidermidis bacteria were not just
surviving within the tissue surrounding implants but that they
had actually replicated between 14 and 21 days after challenge.
DISCUSSION
We previously showed that S. epidermidis is present in high
numbers in tissue surrounding implants in experimental bio-
material-associated infection in mice (3–5, 7, 8) as well as
around catheters in deceased patients (9). In the present study,
we used BrdU to be able to microscopically detect replicated
bacteria in situ. Indeed, replication of bacteria was shown to
occur within tissue surrounding catheters from deceased inten-
sive care unit (ICU) patients. In our mouse BAI model we
subsequently showed, both by CFU counts and BrdU incorpo-
ration, that S. epidermidis replicated within peri-implant tissue
between 14 and 21 days after challenge. These data provide
evidence that the bacteria were not just persisting but were
actually able to multiply while residing within the tissue sur-
rounding the biomaterial implants.
Studies with BrdU have mainly been performed on eukary-
otic cells (12, 30, 31, 37, 40) and marine (27, 38) and soil
bacteria (2, 6, 44). To the best of our knowledge, this is the first
study where BrdU incorporation has been used to detect rep-
licating S. epidermidis. Previously, S. epidermidis bacteria have
been detected by fluorescence microscopy (29, 32), green flu-
orescent protein expressed in the bacteria (15, 28), bacterial
luminescence (20, 42), PCR (1, 19, 34), and culture techniques
(13, 36). None of the above described methods, however, al-
lows the possibility of microscopic detection in situ by labeling
viable cells at specific time points. A new method used to study
Staphylococcus aureus biomaterial-associated infection is bio-
luminescence imaging using the IVIS imaging system. This is a
powerful method that allows infection to be monitored longi-
tudinally and nondestructively in the same animal throughout
the duration of an experiment but does not offer the possibility
FIG. 4. Effect of dexamethasone on biomaterial and tissue colonization by S. epidermidis RP62a in the mouse model. Frequencies of positive
cultures and total numbers of CFU cultured from the 12-mm-diameter tissue biopsy specimens (T) and from the biomaterial implants (BM) of
C57BL/6 mice at 14 and 21 days after challenge with 1  107 CFU of S. epidermidis RP62a are indicated. Frequencies of positive cultures are given
above the lanes. *, P  0.05.
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of microscopic detection of pathogens (14). BrdU incorpora-
tion thus complements the above methods. It allows studies of
the spatio-temporal distribution of viable bacteria at the cel-
lular level during the infectious process.
In order to assess whether BrdU-incorporating bacteria
could also be identified in host cells and tissues, we investi-
gated pericatheter tissue of deceased patients. We previously
reported that this tissue is an additional niche for bacteria
potentially causing catheter-associated infections. In 26% of
the cases, the pericatheter tissue samples were positive in cul-
ture, whereas the corresponding catheter samples yielded
lower numbers of bacteria or were culture negative (9). In the
present study, we microscopically detected BrdU incorpora-
tion ex vivo in bacteria within tissue from deceased patients
from the study described above. This shows that viable bacteria
present in the tissue can be identified and localized by this
approach. Furthermore, this is additional evidence that tissue
surrounding a foreign body is, indeed, a niche for bacteria.
van Diepen et al. (39) used gamma irradiation to reactivate
Salmonella enterica serovar Typhimurium infection in a mouse
intestinal infection model at a time point when bacteria were
undetectable by culture. After total body irradiation, the num-
bers of bacteria in liver and spleen increased to numbers sim-
ilar to those in the primary infection, indicating that by gamma
irradiation, assumed to cause immunosuppression, reactivation
of a Salmonella infection can take place.
In our study we aimed to cause immune suppression with
dexamethasone in order to reactivate the S. epidermidis infec-
tion. We challenged mice with a small inoculum of 106 CFU of
S. epidermidis RP62a since after 14 days only a few S. epider-
midis bacteria persist (4, 8). This, then, was considered the
optimal starting point to suppress the immune system in order
FIG. 5. Light microscopy of biopsy specimen slides of mice that received subcutaneous BrdU injections (top panels) and of one group of
mice that additionally received intraperitoneal dexamethasone injections (bottom panels). BrdU incorporation is shown by the brown staining. Bar,
10 m.
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to reactivate the infection. However, numbers of S. epidermidis
CFU increased not only in the dexamethasone group but also
in the controls receiving only BrdU with saline. Confocal mi-
croscopy of tissue biopsy specimens clearly showed double-
labeled bacteria which were positive for both LTA and BrdU,
indicating that the bacteria had replicated. The increase in
numbers of bacteria may have been due to the fact that S.
epidermidis can multiply in peri-implant tissue even without
immune suppression (3). Alternatively, an immune-suppres-
sive effect of BrdU might have contributed to survival although
we are not aware of reports describing immune suppression by
BrdU.
Evidence of the importance of bacterial colonization of tis-
sue surrounding biomedical implants in biomaterial-associated
infection is increasing. Recent studies using IVIS have indi-
cated that S. aureus colonizes the tissue surrounding abdomi-
nal wall meshes implanted in a mouse infection model (14).
Virden et al. investigated tissue surrounding breast implants
and were able to culture bacteria from the tissue of a patient
although the implant itself was culture negative (41). In cases
of infected hip prostheses, bacteria were observed within fi-
broblasts in the bone tissue surrounding the metal prosthesis
(26). As bacteria are present and able to replicate in the tissue
and therefore are not entirely removed by removal of the
infected device, the tissue may be a reservoir for reinfection. It
is well known that BAI in total hip revisions are often recur-
rent, particularly if a new implant is inserted too soon and
without proper antibiotic treatment. Prolonged antibiotic
treatment is often required before a novel prosthesis can be
placed with a relatively low risk of relapse of the infection (33).
The role of tissue as a reservoir for infection is expected to
apply also to other biomedical devices, and this possibility
warrants detailed microscopic investigation of tissue around
retrieved infected devices and in models of infection.
In conclusion, we developed a method to detect replicating
S. epidermidis within tissue at the microscopic level by appli-
cation of BrdU. Our study shows that replicating bacteria are
present in pericatheter tissue of deceased ICU patients and
that S. epidermidis is able to replicate in peri-implant tissue in
mice between 14 and 21 days after infection with a small
inoculum. This confirms and extends our previous findings that
pericatheter tissue is a reservoir for bacteria in biomaterial-
associated infection, which can now be studied at the micro-
scopic level using BrdU.
ACKNOWLEDGMENTS
We thank Jan van Marle for expert assistance and advice in confocal
microscopy and Leonie de Boer and Jan Stap for assistance with and
advice on fluorescence microscopy.
REFERENCES
1. Arciola, C. R., S. Collamati, E. Donati, and L. Montanaro. 2001. A rapid
PCR method for the detection of slime-producing strains of Staphylococcus
epidermidis and S. aureus in periprosthesis infections. Diagn. Mol. Pathol.
10:130–137.
2. Artursson, V., and J. K. Jansson. 2003. Use of bromodeoxyuridine immu-
nocapture to identify active bacteria associated with arbuscular mycorrhizal
hyphae. Appl. Environ. Microbiol. 69:6208–6215.
3. Boelens, J. J., J. Dankert, J. L. Murk, J. J. Weening, T. Van der Poll, K. P.
Dingemans, L. Koole, J. D. Laman, and S. A. J. Zaat. 2000. Biomaterial-
associated persistence of Staphylococcus epidermidis in pericatheter macro-
phages. J. Infect. Dis. 181:1337–1349.
4. Boelens, J. J., S. A. J. Zaat, J. L. Murk, J. J. Weening, T. Van der Poll, and
J. Dankert. 2000. Enhanced susceptibility to subcutaneous abscess formation
and persistent infection around catheters is associated with sustained inter-
leukin-1	 levels. Infect. Immun. 68:1692–1695.
5. Boelens, J. J., S. A. J. Zaat, J. Meeldijk, and J. Dankert. 2000. Subcutaneous
abscess formation around catheters induced by viable and nonviable Staph-
ylococcus epidermidis as well as by small amounts of bacterial cell wall
components. J. Biomed. Mater. Res. 50:546–556.
6. Borneman, J. 1999. Culture-independent identification of microorganisms
that respond to specified stimuli. Appl. Environ. Microbiol. 65:3398–3400.
7. Broekhuizen, C. A. N., L. de Boer, K. Schipper, C. D. Jones, S. Quadir,
C. M. J. E Vandenbroucke-Grauls, and S. A. J. Zaat. 2008. Staphylococcus
epidermidis is cleared from biomaterial implants but persists in peri-implant
tissue in mice despite rifampicin/vancomycin treatment. J. Biomed. Mater.
Res. A 85:498–505.
8. Broekhuizen, C. A. N., L. de Boer, K. Schipper, C. D. Jones, S. Quadir, R. G.
Feldman, J. Dankert, C. M. J. E. Vandenbroucke-Grauls, J. J. Weening, and
S. A. J. Zaat. 2007. Peri-implant tissue is an important niche for Staphylo-
coccus epidermidis in experimental biomaterial-associated infection in mice.
Infect. Immun. 75:1129–1136.
9. Broekhuizen, C. A. N., M. J. Schultz, A. van der Wall, L. Boszhard,
C. M. J. E. Vandenbroucke-Grauls, and S. A. J. Zaat. 2008. Tissue around
catheters is a niche for bacteria associated with medical device infection.
Crit. Care Med. 36:2395–2402.
10. Caplan, M. J., and F. P. Koontz. 2001. Cumitech 35: postmortem microbi-
ology. ASM Press, Washington, DC.
11. Crnich, C. J., and D. G. Maki. 2002. The promise of novel technology for the
prevention of intravascular device-related bloodstream infection. I. Patho-
genesis and short-term devices. Clin. Infect. Dis. 34:1232–1242.
12. Dayer, A. G., A. A. Ford, K. M. Cleaver, M. Yassaee, and H. A. Cameron.
2003. Short-term and long-term survival of new neurons in the rat dentate
gyrus. J. Comp. Neurol. 460:563–572.
13. Dunne, W. M., Jr., L. K. Case, L. Isgriggs, and D. M. Lublin. 2005. In-house
validation of the BACTEC 9240 blood culture system for detection of bac-
terial contamination in platelet concentrates. Transfusion 45:1138–1142.
14. Engelsman, A. F., H. C. van der Mei, K. P. Francis, H. J. Busscher, R. J.
Ploeg, and G. M. van Dam. 2009. Real time noninvasive monitoring of
contaminating bacteria in a soft tissue implant infection model. J. Biomed.
Mater. Res. B Appl. Biomater. 88:123–129.
15. Franke, G. C., S. Dobinsky, D. Mack, C. J. Wang, I. Sobottka, M. Christner,
J. K. Knobloch, M. A. Horstkotte, M. Aepfelbacher, and H. Rohde. 2007.
Expression and functional characterization of gfpmut3.1 and its unstable
variants in Staphylococcus epidermidis. J. Microbiol. Methods 71:123–132.
16. Gottenbos, B., H. C. van der Mei, F. Klatter, P. Nieuwenhuis, and H. J.
Busscher. 2002. In vitro and in vivo antimicrobial activity of covalently
coupled quaternary ammonium silane coatings on silicone rubber. Biomate-
rials 23:1417–1423.
17. Go¨tz, F. 2002. Staphylococcus and biofilms. Mol. Microbiol. 43:1367–1378.
18. Hewitt, R., J. C. Suit, and D. Billen. 1967. Utilization of 5-bromouracil by
thymineless bacteria. J. Bacteriol. 93:86–89.
19. Kobayashi, N., T. W. Bauer, H. Sakai, D. Togawa, I. H. Lieberman, T.
Fujishiro, and G. W. Procop. 2006. The use of newly developed real-time
PCR for the rapid identification of bacteria in culture-negative osteomyelitis.
Joint Bone Spine 73:745–747.
20. Kodjikian, L., C. Burillon, C. Roques, G. Pellon, J. Freney, and F. N.
Renaud. 2003. Bacterial adherence of Staphylococcus epidermidis to intraoc-
ular lenses: a bioluminescence and scanning electron microscopy study. In-
vest. Ophthalmol. Vis. Sci. 44:4388–4394.
21. Krimmer, V., H. Merkert, E. C. von, M. Frosch, J. Eulert, J. F. Lohr, J.
Hacker, and W. Ziebuhr. 1999. Detection of Staphylococcus aureus and
Staphylococcus epidermidis in clinical samples by 16S rRNA-directed in situ
hybridization. J. Clin. Microbiol. 37:2667–2673.
22. Lehrer, R. I., A. Barton, K. A. Daher, S. S. Harwig, T. Ganz, and M. E.
Selsted. 1989. Interaction of human defensins with Escherichia coli. Mech-
anism of bactericidal activity. J. Clin. Invest. 84:553–561.
23. Mack, D., H. Rohde, L. G. Harris, A. P. Davies, M. A. Horstkotte, and J. K.
Knobloch. 2006. Biofilm formation in medical device-related infection. Int. J.
Artif. Organs 29:343–359.
24. Matsuhisa, A., Y. Saito, H. Ueyama, Y. Aikawa, and T. Ohono. 1994. De-
tection of staphylococci in mouse phagocytic cells by in situ hybridization
using biotinylated DNA probes. Biotech. Histochem. 69:31–37.
25. Mermel, L. A. 2000. Prevention of intravascular catheter-related infections.
Ann. Intern. Med. 132:391–402.
26. Ochsner, P. E., and S. Hailemariam. 2006. Histology of osteosynthesis as-
sociated bone infection. Injury 37(Suppl. 2):S49–S58.
27. Pernthaler, A., J. Pernthaler, M. Schattenhofer, and R. Amann. 2002. Iden-
tification of DNA-synthesizing bacterial cells in coastal North Sea plankton.
Appl. Environ. Microbiol. 68:5728–5736.
28. Rani, S. A., B. Pitts, H. Beyenal, R. A. Veluchamy, Z. Lewandowski, W. M.
Davison, K. Buckingham-Meyer, and P. S. Stewart. 2007. Spatial patterns of
DNA replication, protein synthesis, and oxygen concentration within bacte-
rial biofilms reveal diverse physiological states. J. Bacteriol. 189:4223–4233.
29. Rani, S. A., B. Pitts, and P. S. Stewart. 2005. Rapid diffusion of fluorescent
VOL. 78, 2010 MICROSCOPIC DETECTION OF S. EPIDERMIDIS USING BrdU 961
 o
n
 D
ecem
ber 12, 2011 by VRIJE UNIVERSITEIT
http://iai.asm
.org/
D
ow
nloaded from
 
tracers into Staphylococcus epidermidis biofilms visualized by time lapse
microscopy. Antimicrob. Agents Chemother. 49:728–732.
30. Renno, T., M. Hahne, and H. R. MacDonald. 1995. Proliferation is a pre-
requisite for bacterial superantigen-induced T cell apoptosis in vivo. J. Exp.
Med. 181:2283–2287.
31. Salimi, K., K. V. Moser, J. Marksteiner, M. Reindl, and C. Humpel. 2003.
GDNF and TGF-beta1 promote cell survival in serum-free cultures of pri-
mary rat microglia. Cell Tissue Res. 312:135–139.
32. Seaver, M., J. C. Crookston, D. C. Roselle, and S. J. Wagner. 2001. First
results using automated epifluorescence microscopy to detect Escherichia
coli and Staphylococcus epidermidis in WBC-reduced platelet concentrates.
Transfusion 41:1351–1355.
33. Steckelberg, J. M., and D. R. Osmon. 2000. Prosthetic joint infections, p.
173–210. In F. A. Waldvogel and A. L. Bisno (ed.), Infections associated with
indwelling medical devices, 3rd ed. ASM Press, Washington DC.
34. Stoodley, P., S. Kathju, F. Z. Hu, G. Erdos, J. E. Levenson, N. Mehta, B.
Dice, S. Johnson, L. Hall-Stoodley, L. Nistico, N. Sotereanos, J. Sewecke,
J. C. Post, and G. D. Ehrlich. 2005. Molecular and imaging techniques for
bacterial biofilms in joint arthroplasty infections. Clin. Orthop. Relat. Res.
437:31–40.
35. Szkaradkiewicz, A., M. Wal, J. Jaroszewski, and A. Jopek. 2000. Application
of bromodeoxyuridine (BrdU)-labelled Escherichia coli strains in studies on
their adherence to human endothelial cells. World J. Microbiol. Biotechnol.
16:85–86.
36. Thuret, G., A. Carricajo, C. Chiquet, A. C. Vautrin, N. Celle, M. Boureille,
S. Acquart, G. Aubert, J. Maugery, and P. Gain. 2002. Sensitivity and rapid-
ity of blood culture bottles in the detection of cornea organ culture media
contamination by bacteria and fungi. Br. J. Ophthalmol. 86:1422–1427.
37. Tough, D. F., and J. Sprent. 1998. Lifespan of gamma/delta T cells. J. Exp.
Med. 187:357–365.
38. Urbach, E., K. L. Vergin, and S. J. Giovannoni. 1999. Immunochemical
detection and isolation of DNA from metabolically active bacteria. Appl.
Environ. Microbiol. 65:1207–1213.
39. van Diepen, A., J. S. van de Gevel, M. M. Koudijs, F. Ossendorp, H. Beekhui-
zen, R. Janssen, and J. T. van Dissel. 2005. Gamma irradiation or CD4-
T-cell depletion causes reactivation of latent Salmonella enterica serovar
Typhimurium infection in C3H/HeN mice. Infect. Immun. 73:2857–2862.
40. Vasseur, F., A. Le Campion, J. H. Pavlovitch, and C. Penit. 1999. Distribu-
tion of cycling T lymphocytes in blood and lymphoid organs during immune
responses. J. Immunol. 162:5164–5172.
41. Virden, C. P., M. K. Dobke, P. Stein, C. L. Parsons, and D. H. Frank. 1992.
Subclinical infection of the silicone breast implant surface as a possible cause
of capsular contracture. Aesthetic Plast. Surg. 16:173–179.
42. Vuong, C., S. Kocianova, J. Yu, J. L. Kadurugamuwa, and M. Otto. 2008.
Development of real-time in vivo imaging of device-related Staphylococcus
epidermidis infection in mice and influence of animal immune status on
susceptibility to infection. J. Infect. Dis. 198:258–261.
43. Vuong, C., and M. Otto. 2002. Staphylococcus epidermidis infections. Mi-
crobes Infect. 4:481–489.
44. Yin, B., D. Crowley, G. Sparovek, W. J. De Melo, and J. Borneman. 2000.
Bacterial functional redundancy along a soil reclamation gradient. Appl.
Environ. Microbiol. 66:4361–4365.
Editor: A. Camilli
962 BROEKHUIZEN ET AL. INFECT. IMMUN.
 o
n
 D
ecem
ber 12, 2011 by VRIJE UNIVERSITEIT
http://iai.asm
.org/
D
ow
nloaded from
 
